1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > Diagnostic Imaging Market Trends
  5. > Clinical Imaging: Market and Outsourcing Dynamics

Clinical Imaging: Market and Outsourcing Dynamics

  • June 2014
  • -
  • Industry Standard Research
  • -
  • 134 pages

Clinical imaging has become an integral part of the extensive and expensive research and development process of the pharmaceutical and biotechnology industries. Clinical imaging modalities such as magnetic resonance images (MRI), computed topography scans (CT), and x-rays are fundamental in testing the safety and efficacy of drugs in development phases I through IV.

This report offers two unique perspectives to the clinical imaging service provider market based on the surveys ISR has administered – one from the perspective of companies who currently outsource their imaging services and another from the actual imaging service providers.

Table Of Contents

Clinical Imaging: Market and Outsourcing Dynamics
Copyright and usage guidelines 7
Introduction 9
Report benefits 10
Report sections 11
Methodology and sources 12
Executive Summary 13
Imaging provider characteristics 14
Differentiating imaging-dedicated and full-service CROs 15
Trends amongst companies that outsource imaging services 16
Overview of imaging service provider capabilities 17
Overview of company profile results 18
ClinicalTrials.gov summary data 19
Demographics and responsibilities of respondents outsourcing imaging services …………………………………...20
Respondent demographics 21
Type of organization 21
Job titles of respondents 22
Corporate headquarters location 22
Office location 23
Functional areas of responsibility 24
Primary functional responsibility 25
Respondent roles in selecting outsourcing vendors 26
Perspectives on outsourcing imaging services 27
Use of imaging modalities 28
Imaging modalities used in past 12 months 28
Growth/decline in use of imaging modalities 29
How imaging is utilized 30
Imaging needs met by clinical vs. molecular imaging 30
Anticipated imaging needs met by clinical vs. molecular imaging 30
Centralized vs. decentralized approach to image reading 31
Preference for centralized vs. decentralized approach to image reading 31
Perceived value of imaging service providers 32
Projected growth/decline in imaging studies - 18 month projection 32
Experiences and practices of companies outsourcing imaging services 33
Familiarity with imaging service providers 34
Level of involvement with imaging trials 34
Familiarity with imaging service providers 35
Familiarity with specific imaging service providers 36
Preferred attributes of imaging service providers 37
Top 5 attributes of imaging service providers - selected by those outsourcing the service 37
Top 3 attributes of imaging service providers - selected by those outsourcing the service 37
Top attribute of imaging service providers - selected by those outsourcing the service 38
Imaging outsourcing market 39
Likelihood to outsource specific imaging services 39
Percent of imaging services that are outsourced 40
Percent of imaging services to be outsourced - 18 month projection 40
Current use of imaging within clinical trials 41
All technologies 43
Number of clinical imaging trials by phase 43
Number of clinical imaging trials by phase - industry only 43
Average number of patients in clinical imaging trials by phase 44
Average number of patients in clinical imaging trials by phase - industry only ……………………………...45
Clinical imaging trails by sponsor company 46
Clinical imaging trials by sponsor type 47
Number of interventional imaging trials by phase 47
Number of interventional imaging trials by phase - industry only 48
Average number of patients in interventional imaging trials by phase 48
Average number of patients in interventional imaging trials by phase - industry only 49
MRI 50
Number of clinical imaging trials by phase 50
Number of clinical imaging trials by phase - industry only 50
Average number of patients in clinical imaging trials by phase 51
Average number of patients in clinical imaging trials by phase - industry only……………………………...52
MRI clinical imaging trails by sponsor company 53
Clinical imaging trials by sponsor type 54
Number of interventional imaging trials by phase 54
Number of interventional imaging trials by phase - industry only 55
Average number of patients in interventional imaging trials by phase 56
Average number of patients in interventional imaging trials by phase - industry only 57
PET 58
Number of clinical imaging trials by phase 58
Number of clinical imaging trials by phase - industry only 58
Average number of patients in clinical imaging trials by phase 59
Average number of patients in clinical imaging trials by phase - industry only 60
PET clinical imaging trials by sponsor company 61
Clinical imaging trials by sponsor type 62
Number of interventional imaging trials by phase 62
Number of interventional imaging trials by phase - industry only 63
Average number of patients in interventional imaging trials by phase 64
Average number of patients in interventional imaging trials by phase - industry only 65
Angiograph 66
Number of clinical imaging trials by phase 66
Number of clinical imaging trials by phase - industry only 66
Average number of patients in clinical imaging trials by phase 67
Average number of patients in clinical imaging trials by phase - industry only 68
Angiograph clinical imaging trails by sponsor company 69
Clinical imaging trials by sponsor type 70
Number of interventional imaging trials by phase 71
Number of interventional imaging trials by phase- industry only 71
Average number of patients in interventional imaging trials by phase 72
Average number of patients in interventional imaging trials by phase - industry only 73
ECG 74
Number of clinical imaging trials by phase 74
Number of clinical imaging trials by phase - industry only 74
Average number of patients in clinical imaging trials by phase 75
Average number of patients in clinical imaging trials by phase - industry only……………………………...76
ECG clinical imaging trials by sponsor company 77
Clinical imaging trials by sponsor type 77
Number of interventional imaging trials by phase 78
Number of interventional imaging trials by phase - industry only 78
Average number of patients in interventional imaging trials by phase 79
Average number of patients in interventional imaging trials by phase - industry only 80
Tomograph 81
Number of clinical imaging trials by phase 81
Number of clinical imaging trials by phase - industry only 81
Average number of patients in clinical imaging trials 82
Average number of patients in clinical imaging trials by phase - industry only……………………………...83
Tomograph clinical imaging trails by sponsor company 84
Clinical imaging trails by sponsor type 85
Number of interventional imaging trials by phase 85
Number of interventional imaging trials by phase - industry only 86
Average number of patients in interventional imaging trials by phase 87
Average number of patients in interventional imaging trials by phase - industry only 88
Ultrasound 89
Number of clinical imaging trials by phase 89
Number of clinical imaging trials by phase - industry only 89
Average number of patients in clinical imaging trials by phase 90
Average number of patients in clinical imaging trials by phase- industry only ……………………………...91
Ultrasound clinical imaging trails by sponsor company 92
Clinical imaging trials by sponsor type 93
Number of interventional imaging trials by phase 93
Number of interventional imaging trials by phase - industry only 94
Average number of patients in interventional imaging trials by phase 95
Average number of patients in interventional imaging trials by phase - industry only 95
X-ray 96
Number of clinical imaging trials by phase 96
Number of clinical imaging trials by phase - industry only 96
Average number of patient in clinical imaging trials by phase 97
Average number of patient in clinical imaging trials by phase - industry only ……………………………....98
X-ray clinical imaging trails by sponsor company 99
Clinical imaging trials by sponsor type 100
Number of interventional imaging trials by phase 100
Number of interventional imaging trials by phase - industry only 101
Average number of patients in interventional imaging trials by phase 102
Average number of patients in interventional imaging trials by phase - industry only 103
SPECT 104
Number of clinical imaging trials by phase 104
Number of clinical imaging trials by phase - industry only 104
Average number of patients in clinical imaging trials by phase 105
Average number of patients in clinical imaging trials by phase - industry only…………………...……….106
Clinical imaging trials by sponsor type 107
SPECT clinical imaging trails by sponsor company 107
Number of interventional imaging trials by phase 108
Number of interventional imaging trials by phase - industry only 108
Average number of patients in interventional imaging trials by phase 109
Average number of patients in interventional imaging trials by phase - industry only 110
Service provider capabilities 111
Capabilities charts 112
Company Profiles 117
Company profiles - Dedicated Imaging CROs 118
Intrinsic Imaging 118
Radiant Sage 121
Contact list - dedicated imaging CROs 123
Company profiles - Full-Service CROs 124
Bioclinica 124
Biomedical Systems 127
Medpace 130
Contact list - full-service CROs 133
About Industry Standard Research 134

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Global Diagnostic Imaging Market: Future Horizons and Growth Strategies--Business Assessments of Leading Suppliers

Global Diagnostic Imaging Market: Future Horizons and Growth Strategies--Business Assessments of Leading Suppliers

  • $ 14500
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $14,500.  Individual company assessments $2,450.  The report is available by company, section, market segment, and can be custom-tailored to your specific information needs and budget. ...

Ultrasound Market: Future Horizons and Growth Strategies--Business Assessments of Leading Suppliers--M&A, Technological Capabilities, Marketing Tactics, Joint Ventures, Strategic Directions

Ultrasound Market: Future Horizons and Growth Strategies--Business Assessments of Leading Suppliers--M&A, Technological Capabilities, Marketing Tactics, Joint Ventures, Strategic Directions

  • $ 12500
  • Industry report
  • September 2016
  • by Venture Planning Group

Complete report $12,500.  Individual company assessments $1,850.  The report is available by company, section, market segment, and can be custom-tailored to your specific information needs and budget. ...

Global Ultrasound Market: Future Horizons and Growth Strategies--Business Assessments of Leading Suppliers

Global Ultrasound Market: Future Horizons and Growth Strategies--Business Assessments of Leading Suppliers

  • $ 12500
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $12,500.  Individual company assessments $1,850.  The report is available by company, section, market segment, and can be custom-tailored to your specific information needs and budget. ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.